SAR444656
Sponsors
Sanofi-Aventis Recherche & Developpement
Conditions
Dermatitis atopichidradenitis suppurativa
Phase 2
A parallel-group treatment, Phase 2, double-blind, placebo controlled study to evaluate the efficacy and safety of SAR444656 in adult participants with moderate to severe hidradenitis suppurativa.
CompletedCTIS2023-504328-25-00
Start: 2023-12-27End: 2025-06-23Target: 208Updated: 2025-07-03
A multinational, multicenter, double-blind, placebo-controlled phase 2 study to evaluate efficacy and safety of SAR444656 in adult participants with moderate to severe atopic dermatitis.
CompletedCTIS2023-504346-66-00
Start: 2024-02-14End: 2025-11-20Target: 180Updated: 2025-12-02